The American Thyroid Association (ATA) today at its 82 Annual Meeting in Québec City, Québec, Canada named Hossein Gharib, MD, as President-elect, Gregory Randolph, MD, as Treasurer-elect, and Susan Sherman, MD, and James Hennessey, MD, as members of its Board of Directors. Current President-elect Bryan Haugen, MD, assumed the position of President of the ATA.
An iPhone and specially-designed image analysis app is able to diagnose and manage the treatment of hyperthyroidism and hypothyroidism, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
Screening air-dried fine needle aspirations (FNA) for a panel of genetic mutations linked to follicular or papillary thyroid cancer could reduce the need for diagnostic thyroid surgery, according to data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
ew mouse models can help scientists study a rare disease, called SECISBP2 syndrome, that causes abnormal thyroid hormone metabolism, delayed bone maturation, as well as other abnormal characteristics that vary by individual, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
Next-generation sequencing analyses of the follicular variant of papillary thyroid carcinoma may elucidate the biological underpinnings and clinical behavior of an increasingly common disease, according to data presented at the 82nd ATA Annual Meeting in Québec City, Québec, Canada.
A spectrum of disparities exist in the surgical management of well-differentiated thyroid cancer, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
Although age 45 is used to establish staging in well-differentiated papillary thyroid cancer using the American Joint Committee on Cancer and the International Union Against Cancer TNM Classification of Malignant Tumors (TNM) staging system, a new study presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada, suggests that > 65 may be a more accurate age marker for prognosis.
The American Thyroid Association (ATA) today announced that it will offer specialized educational programming for fellows attending 82nd ATA Annual Meeting, in Québec City, Québec, Canada. Fellows can choose from one of three of tracks—clinical, basic science, or surgical–specifically designed to enhance their knowledge of thyroid disease and further their professional development.
The American Thyroid Association (ATA) today honored Antonio Di Cristofano, PhD, of the Albert Einstein College of Medicine in Bronx, New York, with the 2012 Van Meter Award at the 82nd ATA Annual Meeting.
Subclinical hyperthyroidism is not associated with overall or cardiovascular mortality, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
Exposures to perchlorate (ClO4), a compound found at low levels in the environment, and thiocyanate (SCN), a compound found in cigarette smoke and some foods, is unlikely to alter thyroid function in pregnant women and fetuses, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada
Children and young adult thyroid cancer patients who are treated with radioactive iodine have an elevated risk of developing a second primary malignancy, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
Radioactive iodine should only be used in the treatment of some patients with papillary thyroid cancer, according to data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
Thyroid cancer among people with lower socioeconomic status is diagnosed at a more advanced stage, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
Genome-wide epigenomic screening can pinpoint disease-associated variants and identify novel genetic–epigenetic interactions in autoimmune thyroid diseases, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
New mouse models can help scientists study MCT8 deficiency, an inherited genetic disorder affecting children, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
Loss of function in the X-linked immunoglobulin superfamily member 1 (IGSF1) gene causes central hypothyroidism, testicular enlargement, and variable prolactin deficiency, according to data presented at the 82nd Annual Meeting of the American Thyroid Association in Québec City, Québec, Canada.
The American Thyroid Association (ATA) today announced that new clinical practice guidelines for the diagnosis and treatment of hypothyroidism are published in the current issue of Thyroid. The Guidelines were developed jointly by the ATA and the American Association of Clinical Endocrinologists (AACE) and will be presented on Sunday, Sept. 23, during the 82nd Annual Meeting of the American Thyroid Association in Québec City, Québec, Canada.
The American Thyroid Association (ATA) today announced it will honor Fredric Wondisford, MD, of Johns Hopkins University, with the 2012 Sidney Ingbar Distinguished Lectureship Award on Sept. 20 at the 82nd ATA Annual Meeting.
The American Thyroid Association (ATA) today announced it will honor Bryan R. Haugen, MD, of the University of Colorado, with the 2012 Paul Starr Award on Sept. 22 at the 82nd ATA Annual Meeting, in Québec City, Québec, Canada. The Paul Starr Award recognizes an outstanding contribution of an ATA member to clinical thyroidology.
The American Thyroid Association (ATA) today announced today announced it will honor Paul W. Ladenson, MD, of Johns Hopkins University in Baltimore, with the 2012 Lewis E. Braverman Award on Sept. 21 at the 82nd ATA Annual Meeting in Québec City, Québec, Canada. The Lewis E. Braverman Lectureship Award recognizes a member of the ATA who has demonstrated excellence and passion for mentoring fellows, students, and junior faculty and has a long history of productive thyroid research.
The American Thyroid Association (ATA) today announced it will honor Richard T. Kloos, MD, of Veracyte, Inc., with the 2012 Distinguished Service Award on Sept. 21 at the 82nd ATA Annual Meeting, in Québec City, Québec, Canada.
An international community of researchers, clinicians and health care professionals will convene at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada, held Sept. 19 – Sept. 23, to present and discuss today’s most promising clinical, translational, and basic science research focused on thyroid diseases and disorders.
The American Thyroid Association (ATA) today announced that its Alliance for Patient Education will host a public health forum, “Thyroid Disease and You,” as part of the 82nd ATA Annual Meeting, in Québec City, Québec, Canada. This free event will be held on Saturday, Sept. 22, from 1:00-2:00 p.m., at the Hilton Quebec and is open to the general public.
The American Thyroid Association (ATA) today announced it will honor Sandra McLachlan, PhD, of Cedars-Sinai Medical Center in Los Angeles, with the 2012 John B. Stanbury Pathophysiology Medal on Sept. 21 at the 82nd Annual Meeting of the American Thyroid Association in Québec City, Québec, Canada.
The American Thyroid Association (ATA) today announced today announced that Nancy Carrasco, MD, of the Yale School of Medicine, will deliver the plenary lecture on Sept. 20 at the 82nd Annual Meeting of the American Thyroid Association in Québec City, Québec, Canada.
The American Thyroid Association (ATA) today announced today announced that Krishna Chatterjee, MD, of the Institute of Metabolic Science at University of Cambridge (UK), will deliver the plenary lecture on Sept. 22 at the 82nd Annual Meeting of the American Thyroid Association in Québec City, Québec, Canada.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right